These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2940799)

  • 1. Pharmacokinetics of calcium channel blocking agents.
    Anderson P
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():43-57. PubMed ID: 2940799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of calcium ion antagonists.
    Eichelbaum M
    Clin Invest Med; 1980; 3(1-2):13-7. PubMed ID: 7471537
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers: indications and limitations 2. Use in angina and other cardiac disorders.
    Karlsberg RP; Aronow WS
    Postgrad Med; 1982 Nov; 72(5):115-7, 120, 123. PubMed ID: 6215636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
    Piotrovskii VK; Rumiantsev DO; Nikolenko SA; Riabokon OS; Metelitsa VI
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):4-11. PubMed ID: 3957489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers.
    Dipalma JR
    Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium antagonists in patients with cardiovascular disease. Current perspectives.
    Winniford MD; Hillis LD
    Medicine (Baltimore); 1985 Jan; 64(1):61-73. PubMed ID: 3880854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
    Anderson P; BondessoN U; Sylvén C
    Eur J Clin Pharmacol; 1982; 23(1):49-57. PubMed ID: 7128672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of verapamil.
    Hamann SR; Blouin RA; McAllister RG
    Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of calcium channel blocking agents in angina pectoris.
    Breland BD; Boland MJ
    J Miss State Med Assoc; 1984 Mar; 25(3):57-62. PubMed ID: 6371246
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of verapamil in patients with renal failure.
    Mooy J; Schols M; v Baak M; v Hooff M; Muytjens A; Rahn KH
    Eur J Clin Pharmacol; 1985; 28(4):405-10. PubMed ID: 4029246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of controlled-release verapamil in healthy volunteers and patients with hypertension or angina.
    Gupta S; Modi NB; Sathyan G; Ho Pl PL; Aarons L
    Biopharm Drug Dispos; 2002 Jan; 23(1):17-31. PubMed ID: 11891670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE; Keefe DL; Schwartz J; Harapat S; Kirsten EB; Harrison DC
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic comparison of oral and intravenous verapamil in atrial fibrillation.
    Follath F; Fromer M; Meier P; Vozeh S
    Clin Invest Med; 1980; 3(1-2):49-52. PubMed ID: 7009004
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of verapamil plasma levels in stable angina pectoris.
    Frishman W; Kirsten E; Klein M; Pine M; Johnson SM; Hillis LD; Packer M; Kates R
    Am J Cardiol; 1982 Nov; 50(5):1180-4. PubMed ID: 6753558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacokinetics of verapamil and nifedipine].
    Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI
    Farmakol Toksikol; 1985; 48(1):99-109. PubMed ID: 3884367
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs and the heart. III. Calcium antagonists.
    Opie LH
    Lancet; 1980 Apr; 1(8172):806-10. PubMed ID: 6102688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.